Cgpc
Cgpc, officially known as Chang Gung Pharmaceutical Corporation, is a prominent player in the pharmaceutical industry, headquartered in Taiwan (TW). Established in 1964, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, including prescription medications and over-the-counter solutions. With a strong operational presence across Asia, Cgpc is renowned for its commitment to innovation and quality, particularly in the fields of biotechnology and generic pharmaceuticals. The company’s core offerings are distinguished by their rigorous adherence to international standards and a focus on patient safety. Cgpc has achieved notable recognition in the market, positioning itself as a trusted name in healthcare. Its dedication to research and development has led to several key milestones, solidifying its reputation as a leader in the pharmaceutical sector.
DitchCarbon Score
How does Cgpc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Plastic production industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cgpc's score of 28 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cgpc's reported carbon emissions
In 2023, Cgpc reported total carbon emissions of approximately 15130000 kg CO2e for Scope 1, 16830000 kg CO2e for Scope 2, and a significant 139490000 kg CO2e for Scope 3 emissions. This data highlights the company's substantial carbon footprint across all scopes, particularly in Scope 3, which typically includes emissions from the supply chain and product use. Comparatively, in 2022, Cgpc's emissions were recorded at 151239000 kg CO2e for Scope 1, 168141000 kg CO2e for Scope 2, and a staggering 1394848000 kg CO2e for Scope 3 on a global scale. This indicates a consistent trend in high emissions, particularly in Scope 3, which remains a critical area for improvement. Despite the extensive emissions data, Cgpc has not disclosed specific reduction targets or initiatives aimed at mitigating their carbon footprint. The absence of documented reduction strategies suggests a need for enhanced climate commitments to align with industry standards and expectations for sustainability. Overall, Cgpc's emissions data underscores the importance of developing robust climate action plans to address their significant carbon emissions, particularly in Scope 3, and to contribute positively to global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 4,959,000 | 0,000,000 | 0,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 2 | 10,098,000 | 00,000,000 | 0,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cgpc is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
